BAK » Topics » EXHIBIT I Consolidated Income Statement (R$ million)

This excerpt taken from the BAK 6-K filed Aug 12, 2009.

EXHIBIT I
Consolidated Income Statement
(R$ million)

Income Statement    2Q09
(A) 
  1Q09
(B)
  2Q08
 (C)
  Change
(%)
(A)/(B)
  Change
(%)
(A)/(C)
  1H09
(D)
  1H08
(E)
  Change
(%)
(D)/(E)
Gross Revenue    4,753    4,159    5,890    14    (19)   8,912    11,702    (24)
Net Revenue    3,688    3,260    4,628    13    (20)   6,948    9,175    (24)
Cost of good sold    (3,047)   (2,861)   (3,938)     (23)   (5,909)   (7,783)   (24)
Gross Profit    641    398    690    61    (7)   1,039    1,392    (25)
Selling Expenses    (134)   (126)   (133)       (260)   (231)   12 
General and Administrative Expenses    (153)   (115)   (176)   33    (13)   (268)   (347)   (23)
Depreciation and Amortization    (27)   (22)   (143)   20    (81)   (49)   (284)   (83)
Other operating income (expenses)   18    114    (0)   (85)     131    23    483 
Investment in Associating Companies    (2)   (8)   (35)   (71)   (94)   (10)   (49)   (79)
   .Equity Result    (2)   (2)   (23)   (17)   (92)   (4)   (23)   (82)
   .Amortization of goodwill/negative goodwill    (0)   (5)   (12)       (6)   (26)   (77)
Operating profit before financial result    343    241    202    42    70    584    503    16 
Net financial result    1,192    (208)   386      209    984    167    490 
Operating profit (loss)   1,535    33    588      161    1,568    670    134 
Other non-operating revenue (expenses)   (0)   (1)   10        (1)   122   
Profit (loss) before income tax and social contribution    1,535    32    598      157    1,567    793    98 
Income tax / social contribution    (379)   (23)   (186)     103    (401)   (242)   66 
Profit Sharing    -    -    (6)         (13)  
Profit (loss) before minority interest    1,156    10    405      185    1,166    538    117 
Minority Interest    -    -    (1)         (38)  
Net profit / Loss    1,156    10    404      186    1,166    500    133 
 
Earnings (loss) per share (EPS)   2.22    0.02    0.77      187    2.24    0.96    134 
Earnings (loss) per share ex-amortization of goodwill    2.28    0.08    1.03      122    2.37    1.46    62 
 
EBITDA    566    457    557    24      1,023    1,183    (14)
EBITDA Margin    15.3%    14.0%    12.0%    1.3 p.p.    3.3 p.p.    14.7%    12.9%    1.8 p.p. 
-Depreciacion and Amortization    221    209    320      (31)   429    630    (32)
   . Cost    194    186    176      10    380    347    10 
   . Expense    27    22    143    20    (81)   49    284    (83)
 

17


This excerpt taken from the BAK 6-K filed May 7, 2009.

EXHIBIT I
Consolidated Income Statement
(R$ million)

    1Q09
(A)
  4Q08
(B)
  1Q08
(C)
  Change    Change 
 Income Statement          (%)   (%)
          (A)/(B)   (A)/(C)
           
Gross revenue    4,027    5,459    5,629    (26)   (28)
Net revenue    3,155    4,132    4,401    (24)   (28)
Cost of goods sold    (2,769)   (3,433)   (3,733)   (19)   (26)
Gross profit    385    699    668    (45)   (42)
Selling expenses    (121)   (147)   (93)   (18)   29 
General and Administrative expenses    (110)   (162)   (167)   (32)   (34)
Depreciation and amortization 1    (22)   (116)   (140)   (81)   (84)
Other operating income (expenses) 2    117    32    24    270               396 
Investments in Associated Companies    (8)   (2)   (14)   269    (43)
   .Equity Result    (2)   (2)   (0)   39               656 
   .Amortization of goodwill/negative goodwill 3    (5)   (0)   (13)   1,175    (59)
Operating profit before financial result    242    304    278    (20)   (13)
Net financial result    (209)   (2,243)   (219)   (91)   (5)
Operating profit (loss)   33    (1,939)   58      (43)
Other non-operating revenue (expenses)   (1)   (214)   113    (100)  
Profit (loss) before income tax and social contribution    33    (2,153)   171      (81)
Income tax / social contribution    (23)   12    (47)     (52)
Profit Sharing        (6)    
Profit (loss) before minority interest    10    (2,140)   117      (92)
Minority Interest      (0)   (37)    
Net profit / Loss    10    (2,140)   80      (88)
   
Earnings (loss) per share (EPS)   0.02    (4.22)   0.19      (90)
Earnings (loss) per share ex-amortization of goodwill    0.09    (3.93)   0.47      (82)
   
EBITDA    458    565    601    (19)   (24)
EBITDA Margin    14.5%    13.7%    13.7%    0.8 p.p.    0.9 p.p. 
-Depreciacion and Amortization    208    259    310    (20)   (33)
. Cost    186    143    170    30    10 
. Expense    22    116    140    (81)   (84)
   

1 In accordance with Law 11,638, the goodwill based on “future profitability” is no longer amortized, with the respective recoverable amounts tested on an annual basis.
2 Figures for 1Q09 include the non-recurring impact of R$97 million related to the favorable decisions for the lawsuits involving PIS and COFINS taxes that questioned the constitutionality of Law 9,718.
3 Includes amortization of goodwill related to the capital injection of R$5 million at Refinaria Ipiranga.

16


This excerpt taken from the BAK 6-K filed Mar 5, 2009.

EXHIBIT I
Consolidated Income Statement
(R$ million)

Income Statement    4Q08
(A)
  3Q08
(B)
  4Q07
(C)
  Change
(%)
(A)/(B)
  Change
(%)
(A)/(B)
  2008 
(D)
  2007 
(E)
  Change 
(%)
(D)/(E)
Gross revenue    5,436    6,321    6,127    (14)   (11)   23,020    23,844    (3)
Net revenue    4,111    5,032    4,772    (18)   (14)   17,960    18,788    (4)
Cost of goods sold    (3,345)   (4,268)   (3,910)   (22)   (14)   (15,141)   (15,140)  
Gross profit    766    765    862      (11)   2,819    3,648    (23)
Selling expenses    (146)   (128)   (163)   14    (11)   (493)   (585)   (16)
General and Administrative expenses    (162)   (173)   (176)   (7)   (8)   (674)   (726)   (7)
Depreciation and amortization    (146)   (138)   (137)       (544)   (491)   11 
Other operating income (expenses)   31    26      21    560    86    128    (33)
Investments in Associated Companies    23    (9)       620    (64)   (75)   (15)
   .Equity Result    (7)   15    11        (23)   13   
   .Amortization of goodwill/negative goodwill    30    (23)   (8)       (40)   (88)   (54)
Operating profit before financial result    368    344    395      (7)   1,130    1,899    (40)
Net financial result    (2,275)   (1,616)   (137)   41    1,564    (3,685)   (367)   903 
Operating profit (loss)   (1,907)   (1,272)   258    50      (2,554)   1,531   
Other non-operating revenue (expenses)1    (214)   (67)   (41)   217    426    (159)   (69)   129 
Profit (loss) before income tax and social contribution    (2,121)   (1,339)   217    58      (2,713)   1,462   
Income tax / social contribution    12    497    (111)   (97)     278    (412)  
Profit Sharing      (6)   (7)       (19)   (19)  
Profit (loss) before minority interest    (2,108)   (849)   99    148      (2,454)   1,031   
Minority Interest    (0)   (0)         (39)   (389)   (90)
Net profit / Loss    (2,108)   (849)   101    148      (2,492)   642   
 
Earnings (loss) per share (EPS)   (4.15)   (1.62)   0.23    157      (4.91)   1.43   
Earnings (loss) per share ex-amortization of goodwill    (3.87)   (1.39)   0.48    179      (4.02)   2.18   
 
EBITDA    633    683    721    (7)   (12)   2,418    3,250    (26)
EBITDA Margin    15.4%    13.6%    15.1%    1.8 p.p.    0.3 p.p.    13.5%    17.3%    -3.8 p.p. 
-Depreciacion and Amortization    289    330    329    (13)   (12)   1,224    1,276    (4)
     . Cost    143    193    193    (26)   (26)   681    785    (13)
     . Expense    146    138    137        544    491    11 
 
1 In 3Q08, includes R$ 42 million from the reversal of technological sale to Petroquímica Paulínia given the incorporation by Braskem 

21



This excerpt taken from the BAK 6-K filed Aug 6, 2008.

EXHIBIT I
Consolidated Income Statement (1)

(R$ million)

Income Statement    2Q08
(A)
  1Q08
(B)
  2Q07
 (C)
  Change
(%)
(A)/(B)
  Change
(%)
(A)/(C)
  1H08
(D)
  1H07
(E)
  Change
 (%)
(D)/(E)
Gross revenue    5,625    5,638    6,161    (0)   (9)   11,263    11,781    (4)
Net revenue    4,405    4,410    4,969    (0)   (11)   8,816    9,393    (6)
Cost of goods sold    (3,768)   (3,760)   (4,037)     (7)   (7,528)   (7,449)  
Gross profit    637    650    932    (2)   (32)   1,288    1,944    (34)
Selling expenses    (126)   (93)   (128)   36    (1)   (220)   (295)   (26)
General and Administrative expenses    (172)   (167)   (205)     (16)   (339)   (382)   (11)
Depreciation and amortization    (130)   (131)   (122)   (1)     (260)   (230)   13 
Other operating income (expenses)     24    120    (79)   (96)   29    116    (75)
Investments in Associated Companies    (57)   (22)   (22)   164    162    (78)   (57)   38 
   .Equity Result    (33)           (32)    
   .Amortization of goodwill/negative goodwill    (24)   (23)   (22)     10    (47)   (59)   (20)
Operating profit before financial result    157    261    575    (40)   (73)   419    1,096    (62)
Net financial result    407    (200)   (59)       206    (163)  
Operating profit (loss)   564    61    516    829      625    933    (33)
Other non-operating revenue (expenses)   10    113    (22)   (91)     122    (25)  
Profit (loss) before income tax and social contribution    574    173    494    231    16    747    908    (18)
Income tax / social contribution    (184)   (47)   (70)   288    163    (231)   (208)   11 
Profit Sharing    (6)   (6)   (5)     26    (13)   (5)   146 
Profit (loss) before minority interest    384    120    420    220    (8)   504    695    (28)
Minority Interest    (1)   (37)   (138)   (97)   (99)   (38)   (287)   (87)
Net profit (loss)   383    83    281    362    36    465    408    14 
 
Earnings per share (EPS)   0.73    0.19    0.76    283    (3)   0.89    1.10    (19)
Earnings per share ex-amortization of goodwill    0.98    0.49    1.08    101    (9)   1.39    1.69    (18)
 
EBITDA    519    583    921    (11)   (44)   1,102    1,774    (38)
EBITDA Margin    11.8%    13.2%    18.5%    -1.4 p.p.    -6.7 p.p.    12.5%    18.9%    -6.4 p.p. 
-Depreciacion and Amortization    305    300    324      (6)   605    621    (2)
   . Cost    175    170    202      (13)   345    391    (12)
   . Expense    130    131    122    (1)     260    230    13 
 
(1) Considers the effects of the acquisition of petrochemical assets of Grupo Ipiranga as of January 1st, 2006

16



This excerpt taken from the BAK 6-K filed May 7, 2008.

EXHIBIT I
Consolidated Income Statement (1)
(R$ million)

Income Statement    1Q08    4Q07    1Q07   Change (%)   Change (%)
  (A)    (B)    (C)   (A)/(B)   (A)/(C)
   Gross revenue    5,638    6,153    5,620    (8)  
   Net revenue    4,410    4,809    4,424    (8)   (0)
   Cost of goods sold    (3,760)   (4,019)   (3,412)   (6)   10 
   Gross profit    650    789    1,012    (18)   (36)
   Selling expenses    (93)   (163)   (168)   (43)   (44)
   General and Administrative expenses    (167)   (176)   (176)   (5)   (5)
   Depreciation and amortization    (131)   (129)   (108)     21 
   Other operating income (expenses)   24      (4)   396   
   Investments in Associated Companies    (22)   (39)   (35)   (45)   (39)
       • Equity Result          32    (39)
       • Amortization of goodwill/negative goodwill    (23)   (40)   (37)   (44)   (39)
   Operating profit before financial result    261    287    521    (9)   (50)
   Net financial result    (200)   (54)   (104)   274    94 
   Operating profit (loss)   61    233    417    (74)   (85)
   Other non-operating revenue (expenses)   113    (41)   (4)    
   Profit (loss) before income tax and social contribution    173    193    413    (10)   (58)
   Income tax / social contribution    (47)   (161)   (138)   (70)   (66)
   Profit Sharing    (6)   (7)     (13)  
   Profit (loss) before minority interest    120    25    275    379    (56)
   Minority Interest    (37)     (148)     (75)
   Net profit (loss)   83    27    127    204    (35)
   
   Earnings per share (EPS)   0.19    0.06    0.34    215    (44)
   Earnings per share ex-amortization of goodwill    0.42    0.30    0.62    43    (32)
   
   EBITDA    583    648    853    (10)   (32)
   EBITDA Margin    13.2%    13.5%    19.3%    -0.3 p.p.   -6.1 p.p. 
   -Depreciacion and Amortization    300    322    297    (7)  
        • Cost    170    193    189    (12)   (10)
        • Expense    131    129    108      21 
     
 
(1) Considers the effects of the acquisition of petrochemical assets of Grupo Ipiranga as of January 1st, 2006     

18



This excerpt taken from the BAK 6-K filed Nov 7, 2007.

EXHIBIT I
Consolidated Income Statement (1)

(R$ million)

Income Statement    3Q07
(A)
  2Q07
(B)
  3Q06
(C)
 

change
(%)
(A)/(B)

  change
(%)
(A)/(C)
  9M07
(D)
  9M06*
(E)
  change
(%)
(D)/(E)
Gross revenue    5,936    6,161    5,987    (4)   (1)   17,717    16,293   
Net revenue    4,623    4,969    4,724    (7)   (2)   14,016    12,746    10 
Cost of goods sold    (3,782)   (4,037)   (3,867)   (6)   (2)   (11,231)   (10,566)  
Gross profit    841    932    858    (10)   (2)   2,785    2,180    28 
Selling expenses    (126)   (128)   (120)   (1)     (421)   (345)   22 
General and Administrative expenses    (169)   (205)   (173)   (18)   (2)   (550)   (497)   11 
Depreciation and amortization    (125)   (122)   (104)     20    (355)   (298)   19 
Other operating income (expenses)     120    26    (94)   (71)   123    152    (19)
Investments in Associated Companies    (21)   (22)   (26)   (2)   (19)   (78)   (12)   539 
   .Equity Result        11      (99)     67    (97)
   .Amortization of goodwill/negative goodwill    (21)   (22)   (37)   (4)   (43)   (80)   (79)  
Operating profit before financial result    408    575    460    (29)   (11)   1,504    1,179    28 
Net financial result    (68)   (59)   (396)   15    (83)   (231)   (753)   (69)
Operating profit (loss)   340    516    64    (34)   428    1,273    426    199 
Other non-operating revenue (expenses)   (3)   (22)     (85)     (29)   (1)   1,920 
Profit (loss) before income tax and social contribution    337    494    65    (32)   420    1,245    425    193 
Income tax / social contribution    (93)   (70)   (25)   34    276    (301)   (69)   335 
Profit Sharing    (7)   (5)     27      (12)    
Profit (loss) before minority interest    237    420    40    (43)   493    932    356    162 
Minority Interest    (105)   (138)   (94)   (24)   11    (391)   (318)   23 
Net profit (loss)   132    281    (54)   (53)     541    38    1,331 
 
Earnings per share (EPS)   0.29    0.63    (0.12)   (53)     1.20    0.08    1,331 
Earnings per share ex-amortization of goodwill    0.54    0.88    0.11    (39)   405    1.92    1.41    36 
 
EBITDA    755    921    795    (18)   (5)   2,529    2,085    21 
EBITDA Margin    16.3%    18.5%    16.8%    -2.2p.p.    -0.5 p.p.    18.0%    16.4% +1.6 p.p. 
-Depreciacion and Amortization    326    324    308        947    894   
     . Cost    201    202    205    (0)   (2)   592    596    (1)
     . Expense    125    122    104      20    355    298    19 
 
(1) Consider the effects of the acquisition of the petrochemical assets from the Ipiranga Group since January 1, 2006 
* Includes 100% of Politeno at 1Q06 

19


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki